Defining the Role of Angiotensin II Type 2 Receptor in Bladder Physiology and Pathophysiology with Mouse Models
NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases
About This Grant
PROJECT SUMMARY The complex communication mechanisms involved in bladder function are not fully understood. Due to this lack of physiological understanding, bladder diseases have remained challenging to treat, resulting in severe detriment to patient quality of life, particularly in the case of interstitial cystitis/bladder pain syndrome (IC/BPS). To address this, I aim to contribute to the ongoing investigation of the role of renin-angiotensin signaling in the bladder to inform future therapeutic strategies. Angiotensin II (Ang II) is the primary effector molecule of the renin-angiotensin system, and action on either of its receptors, Ang II type 1 receptor (AT1R) and Ang II type 2 receptor (AT2R), has been shown to elicit major effects in other organ systems. While Ang II signaling research in the bladder has primarily focused on defining the role of AT1R in mediating contractions and pathological effects on bladder tissue, AT2R should also be considered for its potential protective effects. Despite the understanding that AT2R counteracts the pathological impact of AT1R in other organ systems, the role of AT2R in the bladder remains largely unknown. Preliminary investigations have demonstrated that AT2R is expressed in the bladder, and one investigation showed that blocking AT2R in mice worsened the pathological effects in a cystitis model. However, there has not been a comprehensive investigation solely regarding the presence and role of AT2R in the bladder. Given these preliminary findings, I hypothesize that AT2R has a functional role in the bladder, and its activation can alleviate hyperalgesia and bladder dysfunction associated with cystitis conditions. This work will be conducted with two main aims: Aim 1 will provide a physiological evaluation by using naïve mouse bladder tissue to characterize the presence and location of AT2R mRNA expression and define the role of AT2R in ex vivo contractile responses through pharmacological manipulation of AT2R activity; Aim 2 will explore the role of AT2R in a pathophysiological bladder condition in vivo through chronic administration of an AT2R agonist, C21, in a cystitis mouse model. The effect of AT2R activation will be evaluated through voiding function, abdominal hypersensitivity, molecular changes, and ex vivo contractile responses. This work begins to uncover the role of AT2R in bladder physiology and pathology and is the first to broach the potential of AT2R as a therapeutic target for bladder diseases such as IC/BPS. Expanding the knowledge of angiotensin signaling in bladder dysfunction provides a foundation for pharmacological and non-pharmacological interventions that could improve patient outcomes and quality of life. The proposed research will help me develop as an independent scientist, providing me the opportunity to lead an experiment and gain the technical skills needed for a career in science. As a PhD student in the Joint Department of Biomedical Engineering at the Medical College of Wisconsin and Marquette University under mentorship from Dr. Aaron Mickle and Dr. Justin Grobe, I have all the tools necessary to complete this fellowship effectively and obtain preparation for my career.
Grant Summary
Defining the Role of Angiotensin II Type 2 Receptor in Bladder Physiology and Pathophysiology with Mouse Models is a NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases grant providing up to $50K for university, nonprofit, healthcare org. Applications are due 2028-02-12 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $50K
2028-02-12
- 1Confirm your organization is eligible for Defining the Role of Angiotensin II Type 2 Receptor in Bladder Physiology and Pathophysiology with Mouse Models from NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Defining the Role of Angiotensin II Type 2 Receptor in Bladder Physiology and Pathophysiology with Mouse Models: Frequently Asked Questions
Who is eligible for the Defining the Role of Angiotensin II Type 2 Receptor in Bladder Physiology and Pathophysiology with Mouse Models?
Defining the Role of Angiotensin II Type 2 Receptor in Bladder Physiology and Pathophysiology with Mouse Models is offered by NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Defining the Role of Angiotensin II Type 2 Receptor in Bladder Physiology and Pathophysiology with Mouse Models provide?
Defining the Role of Angiotensin II Type 2 Receptor in Bladder Physiology and Pathophysiology with Mouse Models provides up to $50K per award from NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Defining the Role of Angiotensin II Type 2 Receptor in Bladder Physiology and Pathophysiology with Mouse Models deadline?
Applications for Defining the Role of Angiotensin II Type 2 Receptor in Bladder Physiology and Pathophysiology with Mouse Models are due 2028-02-12 (open). Because deadlines can change, verify the date with the funder, NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Defining the Role of Angiotensin II Type 2 Receptor in Bladder Physiology and Pathophysiology with Mouse Models?
To apply for Defining the Role of Angiotensin II Type 2 Receptor in Bladder Physiology and Pathophysiology with Mouse Models, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases.